Genmab A/S (GMAB)
NASDAQ: GMAB · Real-Time Price · USD
26.12
-0.02 (-0.08%)
At close: Jun 26, 2026, 4:00 PM EDT
25.80
-0.32 (-1.23%)
After-hours: Jun 26, 2026, 7:42 PM EDT
Genmab Employees
Genmab had 2,973 employees as of December 31, 2025. The number of employees increased by 339 or 12.87% compared to the previous year.
Employees
2,973
Change (1Y)
339
Growth (1Y)
12.87%
Revenue / Employee
$1,263,277
Profits / Employee
$265,868
Market Cap
15.94B
Employees Chart
Employees History
Related Stocks
| Company Name | Employees |
|---|---|
| BioNTech SE | 7,807 |
| Jazz Pharmaceuticals | 2,890 |
| Incyte | 2,844 |
| Insmed | 1,664 |
| Ionis Pharmaceuticals | 1,402 |
| Axsome Therapeutics | 1,220 |
| Ascendis Pharma | 1,189 |
| Exelixis | 1,077 |
GMAB News
- 10 days ago - Capital Increase in Genmab as a Result of Employee Warrant Exercise - GlobeNewsWire
- 11 days ago - Major Shareholder Announcement - GlobeNewsWire
- 12 days ago - Genmab (GMAB) Reports Promising Results for Epcoritamab in DLBCL Studies - GuruFocus
- 12 days ago - Genmab announces new data from studies evaluating epcoritamab - TheFly
- 13 days ago - Genmab Presents Promising Epcoritamab Data In Elderly DLBCL Patients - Nasdaq
- 13 days ago - Genmab Announces Epcoritamab Monotherapy and Epcoritamab-Based Combination Regimens Demonstrate High Response Rates in Elderly Patients with Newly Diagnosed Diffuse Large B-Cell Lymphoma (DLBCL) - Business Wire
- 15 days ago - Grant of Restricted Stock Units and Warrants to Employees in Genmab - GlobeNewsWire
- 15 days ago - Genmab (GMAB) Reports Strong Data from EPCORE FL-1 Trial Analysis - GuruFocus